# Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)

> **NCT04034056** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 299 (actual)

## Conditions studied

- Follicular Lymphoma

## Interventions

- **DRUG:** Obinutuzumab

## Key facts

- **NCT ID:** NCT04034056
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-02
- **Primary completion:** 2024-04-22
- **Final completion:** 2024-04-22
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04034056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04034056, "Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04034056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*